Viela Bio Competitors, Revenue, Alternatives and Pricing

Claim your profile


Total Funding:$357.3M
Lead Investor(s):Boyu Capital, 6 Dimensions Capital

Estimated Revenue & Financials

  • Viela Bio's estimated annual revenue is currently $10.5M per year.(?)
  • Viela Bio received $250.0M in venture funding in March 2018.
  • Viela Bio's estimated revenue per employee is $155,000
  • Viela Bio's total funding is $357.3M.

Employee Data

  • Viela Bio has 68 Employees.(?)
  • Viela Bio grew their employee count by -51% last year.
  • Viela Bio currently has 7 job openings.

Viela Bio is a clinical-stage biotechnology company pioneering and advancing treatments for severe inflammation and autoimmune diseases. The Company's portfolio selectively targets shared critical pathways that are the root cause of disease. Led by a team of global leaders in inflammation and autoimmunity, Viela Bio strives to be a fully integrated biotechnology company, helping millions of patients worldwide. Viela Bio is located in Gaithersburg, Maryland. Learn more at